SCHEMBL32669882

SCHEMBL32669882

Cc1cc(/C(O)=C(\C#N)C(=O)N(C)CCOc2ccccc2CO)cc(C#N)c1O

nearest known ligand 0.34

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HRH1 P35367 2/20 0.34
ALDH1A1 P00352 4/20 0.33
HPGD P15428 1/20 0.33
KDM4E B2RXH2 2/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
DRD2 P14416 1/20 0.32
DRD1 P21728 1/20 0.32
DRD4 P21917 1/20 0.32
DRD5 P21918 1/20 0.32
LMNA P02545 1/20 0.32
COMT P21964 1/20 0.32
FTO Q9C0B1 1/20 0.32
TSHR P16473 2/20 0.31
NPSR1 Q6W5P4 2/20 0.31
PPARD Q03181 1/20 0.31
RAB9A P51151 1/20 0.30
USP2 O75604 1/20 0.30
MAPK1 P28482 1/20 0.30
SLC6A9 P48067 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32669611 0.84 ALDH1A1 (0.37) ALDH1A1HPGDKDM4ESMN1; SMN2LMNA
SCHEMBL32669776 0.83 GRM2 (0.33) COMTFTO
SCHEMBL32669504 0.81 SLC22A12 (0.32) ALDH1A1HPGDLMNACOMTFTO
SCHEMBL32669826 0.81 USP2 (0.33) USP2MAPK1
SCHEMBL32669597 0.81 ESR1 (0.38) ALDH1A1KDM4ELMNARAB9A
SCHEMBL32669968 0.80 ALDH1A1 (0.36) ALDH1A1HPGDKDM4ECOMTFTO
SCHEMBL32669580 0.80 COMT (0.35) COMTFTO
SCHEMBL32669823 0.80 KMT2A (0.40) ALDH1A1HPGDKDM4ELMNACOMT
SCHEMBL32669989 0.79 SLC6A9 (0.35) ALDH1A1HPGDSMN1; SMN2NPSR1RAB9A
SCHEMBL32670074 0.78 KMT2A (0.39) ALDH1A1SMN1; SMN2LMNACOMTFTO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260035341-A1 FTO INHIBITORS RPXDS CO LTD (CN) 2026-02-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260035341-A1 FTO INHIBITORS FTO, LDLR, GPR119 HRH1 3770/4885ALDH1A1 1334/4885HPGD 3946/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.